Analyst Reports
November 2011
Nomura Equity Research: PRR’s C-Vac is a potentially elegant therapy for recurrent ovarian cancer >>
July 2011
Ord Minnett Research Report >>
May 2011
Southern Cross Equities Research Coverage >>
February 2011
National Securities Research Report >>
September 2010
National Securities Research Report >>
May 2010
Southern Cross Research Report >>
May 2010
National Securities Research Report >>
November 2009
Southern Cross Equities Research Coverage >>
May 2009
ABM AMRO Morgans Healthcare Research >>
May 2009
Kinectic Securities PRR Research >>
April 2009
Bioshares Report on Prima Biomed's Upcoming FDA IN >>
April 2008
WiseOwl Report 1 >>
June 2006
Resource Stocks Magazine profiles Prima Biomed >>
March 2006
Bioshares report on Prima Biomed's Cancer Immunotherapy
approaching crucial revaluation point >>
October 2005Bioshares analysis of agreement with Trillium Therapeutics and corporate strategy >>
|